Home > Clinical Trials

Saved trials

NOT_YET_RECRUITING
NCT07126561
Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers
43 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
HER2 Positive Newly Diagnosed Metastatic Esophageal, Gastric, GEJ Cancer Patients With an ECOG Performance Status of 2
RECRUITING
NCT06324396
IMProving DRug Dosing and Outcomes for Single VEntricle Patients With Fontan Associated Liver Disease
15 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1)
Fontan Circulation
TERMINATED
NCT03820947
VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial
506 Enrollment(s)
32 Study location(s)
INTERVENTIONAL (NA)
Venous Reflux
TERMINATED
NCT03944512
Pravastatin to Prevent Preeclampsia
102 Enrollment(s)
12 Study location(s)
INTERVENTIONAL (PHASE3)
Preeclampsia


Obstetric Labor Complications


Hypertension in Pregnancy
ACTIVE_NOT_RECRUITING
NCT04556773
A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer
138 Enrollment(s)
37 Study location(s)
INTERVENTIONAL (PHASE1)
Metastatic Breast Cancer
RECRUITING
NCT07281001
A Study to Assess the Efficiency of Trastuzumab Deruxtecan in Russian Breast Cancer Patients
60 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (NA)
HER2-positive Breast Cancer


Trastuzumab Deruxtecan
RECRUITING
NCT06085755
Trastuzumab Deruxtecan(T-DXd) and Afatinib Combination in HER2-low Advanced Gastric Cancer
61 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Stomach Neoplasm
COMPLETED
NCT03463317
Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy
912 Enrollment(s)
42 Study location(s)
INTERVENTIONAL (PHASE4)
Atrial Fibrillation